One of 5 microcourses in the What is HEOR? series, this course provides a basic understanding of cost-Effectiveness analyses and how these can help answer questions in our health care systems like:

• Can the health system support the additional cost for each life saved if the new drug is both more costly and more effective than previous therapies?

• If a new drug or device is less costly but less effective than existing therapies, how much of a diminution in efficacy can society/payers/patients withstand in order to save money?

• How much money must be saved in order to make it "cost-effective" to accept a reduction in efficacy over existing strategies?

In this microcourse, you will learn more about the role of cost-effectiveness analysis (CEA) and cost-utility analysis (CUA) in medical decision-making.

After the completion of this course, participants will be able to:

• State the role of cost-effectiveness analysis (CEA) and cost-utility analysis (CUA) in medical decision-making.
• Define the components of CEA and CUA and understand the computations involved in both.
• Understand the concerns in attribution of cost components to a particular treatment arm.

The access period once enrolled into the course is 30 days from the date of purchase. After this duration, you will need to re-enroll if you wish to re-enter the course.

Time to complete – approximately 1 hour

If you are new to health economics and outcomes research, the What is HEOR? course series provides a nice foundation from which to start your learning. Other courses in this series include:

• What is HEOR?
• Patient-reported outcomes (PROs)
• Health-related quality of life measures (HRQOL)
• Budget impact analysis (BIA)

After logging in to enroll, you will have an opportunity to register for one or more of the courses in the series.